On June 22, 2022, NeoGenomics Inc. (NASDAQ: NEO) opened at $7.37, higher 5.61% from the last session. During the day, the shares moved up to $8.135 and dropped to $7.32 before settling in for the closing price of $7.49. Price fluctuations for NEO have ranged from $6.85 to $54.74 over the past 52 weeks.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
A company in the Healthcare sector has jumped its sales by 15.90% annually for the last half of the decade. Company’s average yearly earnings per share was noted -286.40% at the time writing. With a float of $121.37 million, this company’s outstanding shares have now reached $123.63 million.
In an organization with 2000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +37.08, operating margin of -19.66, and the pretax margin is -3.11.
NeoGenomics Inc. (NEO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of NeoGenomics Inc. is 1.50%, while institutional ownership is 91.90%. The most recent insider transaction that took place on Mar 07, was worth 58,693. In this transaction Chief Financial Officer of this company sold 3,209 shares at a rate of $18.29, taking the stock ownership to the 98,516 shares. Before that another transaction happened on Dec 21, when Company’s Chief Financial Officer sold 1,846 for $35.00, making the entire transaction worth $64,610. This insider now owns 11,689 shares in total.
NeoGenomics Inc. (NEO) Latest Financial update
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.2 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.23) by $0.03. This company achieved a net margin of -1.72 while generating a return on equity of -0.93. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -286.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.30% during the next five years compared to 29.40% growth over the previous five years of trading.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Check out the current performance indicators for NeoGenomics Inc. (NEO). In the past quarter, the stock posted a quick ratio of 7.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of NeoGenomics Inc. (NEO)
Let’s dig in a bit further. During the last 5-days, its volume was 2.34 million. That was better than the volume of 1.92 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 44.67%. Additionally, its Average True Range was 0.67.
During the past 100 days, NeoGenomics Inc.’s (NEO) raw stochastic average was set at 6.26%, which indicates a significant decrease from 53.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.40% in the past 14 days, which was lower than the 107.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.26, while its 200-day Moving Average is $26.16. However, in the short run, NeoGenomics Inc.’s stock first resistance to watch stands at $8.26. Second resistance stands at $8.60. The third major resistance level sits at $9.07. If the price goes on to break the first support level at $7.44, it is likely to go to the next support level at $6.97. The third support level lies at $6.63 if the price breaches the second support level.
NeoGenomics Inc. (NASDAQ: NEO) Key Stats
There are currently 124,758K shares outstanding in the company with a market cap of 922.78 million. Presently, the company’s annual sales total 484,330 K according to its annual income of -8,350 K. Last quarter, the company’s sales amounted to 117,170 K and its income totaled -49,410 K.